CN107486037B - A kind of PVDF/PDA composite membrane with super hydrophilicity - Google Patents
A kind of PVDF/PDA composite membrane with super hydrophilicity Download PDFInfo
- Publication number
- CN107486037B CN107486037B CN201710829883.0A CN201710829883A CN107486037B CN 107486037 B CN107486037 B CN 107486037B CN 201710829883 A CN201710829883 A CN 201710829883A CN 107486037 B CN107486037 B CN 107486037B
- Authority
- CN
- China
- Prior art keywords
- pvdf
- pda
- composite membrane
- film
- dopamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920002981 polyvinylidene fluoride Polymers 0.000 title claims abstract description 75
- 229920001690 polydopamine Polymers 0.000 title claims abstract description 64
- 239000012528 membrane Substances 0.000 title claims abstract description 62
- 239000002033 PVDF binder Substances 0.000 title claims abstract description 60
- 239000002131 composite material Substances 0.000 title claims abstract description 43
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims abstract description 88
- 229960003638 dopamine Drugs 0.000 claims abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 238000011065 in-situ storage Methods 0.000 claims abstract description 5
- 238000007792 addition Methods 0.000 claims abstract description 3
- 239000008367 deionised water Substances 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 19
- 235000019441 ethanol Nutrition 0.000 claims description 13
- 239000008363 phosphate buffer Substances 0.000 claims description 10
- JLEXUIVKURIPFI-UHFFFAOYSA-N tris phosphate Chemical compound OP(O)(O)=O.OCC(N)(CO)CO JLEXUIVKURIPFI-UHFFFAOYSA-N 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 230000003139 buffering Effects 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 abstract description 15
- 238000000034 method Methods 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 7
- 230000003373 anti-fouling Effects 0.000 abstract description 6
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 238000003756 stirring Methods 0.000 description 17
- 229960004756 ethanol Drugs 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 9
- 229960000935 Dehydrated Alcohol Drugs 0.000 description 8
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 8
- 239000007983 Tris buffer Substances 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- 206010018910 Haemolysis Diseases 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000006011 modification reaction Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 4
- 230000002949 hemolytic Effects 0.000 description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N Catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N 3-hydroxy-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 206010018913 Haemolysis Diseases 0.000 description 2
- 230000000903 blocking Effects 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003592 biomimetic Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 229920001887 crystalline plastic Polymers 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative Effects 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/30—Polyalkenyl halides
- B01D71/32—Polyalkenyl halides containing fluorine atoms
- B01D71/34—Polyvinylidene fluoride
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0006—Organic membrane manufacture by chemical reactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/12—Composite membranes; Ultra-thin membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/58—Other polymers having nitrogen in the main chain, with or without oxygen or carbon only
- B01D71/60—Polyamines
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/40—Details relating to membrane preparation in-situ membrane formation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/36—Hydrophilic membranes
Abstract
The invention discloses a kind of PVDF/PDA composite membrane with super hydrophilicity, belongs to the compound membrane modifying field of high molecular functional.By the way that dopamine is added in buffer solution, after magnetic agitation 24-72h, addition pvdf membrane, magnetic agitation 3-5 days；A large amount of PDA microballoons in-situ preparation and modified obtained film entirety hydrophiling structure on film upper and lower surfaces and fenestra wall, wherein film section is the spongelike structure being interconnected between PDA microballoon tiling cover film hole wall but fenestra.Due to the presence of film microreactor effect in the good hydrophily of dopamine itself and modifying process, so that modified obtained PVDF/PDA composite membrane hydrophilicity and antifouling property when as water treatment applications film are greatly improved.Modified effect of the present invention is significant, and preparation process is simple, easily operated, low for equipment requirements, is easy to industrializing implementation, in fields such as water process, biomedicines there is potential be widely applied to be worth.
Description
Technical field
The present invention relates to a kind of PVDF/PDA composite membrane with super hydrophilicity, belongs to the compound membrane modifying of high molecular functional
Field.
Background technique
PVDF (Kynoar) is a kind of Crystalline plastics, crystallinity 30%-80%, white granular or powder
Shape.PVDF has good thermal stability, and about 170 DEG C of crystalline melt point, thermal decomposition temperature is at 300 DEG C or more, long-term use temperature
Range is -40 DEG C -150 DEG C；With excellent chemical stability, do not corroded by acid, alkali, oxidant and halogen under room temperature, to rouge
The organic solvents such as fat hydrocarbon, aromatic hydrocarbon, alcohols and aldehydes are very stable, are only soluble in only a few polar solvent, oleum, highly basic etc.；It is mechanical
Performance is prominent, has good impact strength, good toughness, hardness is big, and wear-resisting property is good；And also there is resistance to y outstanding to penetrate
The performances such as line, ultraviolet radiation.Therefore, PVDF is a kind of relatively popular membrane material, and business pvdf membrane is in micro-filtration and ultrafiltration
There is universal application in water process, be applied successfully to drinking water, gas filtration, pollutant removal, solvent refining and film
The fields such as distillation.However, due to the stronger hydrophobicity of pvdf membrane itself, so that it is easy the albumen in absorption water in water process
Matter, oil droplet, colloid or other organic substances and cause Pore Blocking, cause permeation flux, selection performance and service efficiency under
Drop, and when as bio-separation and contacting blood material condensation easy to form, cause complication etc., limit it in water process
And the application in the fields such as biomedicine.Therefore, hydrophilic modification is carried out to pvdf membrane material, pvdf membrane can be effectively improved
Antifouling property, separating property and biological property, and practical application valence of pvdf membrane during socio-economic development will be promoted
Value.
Catechol derivatives of the dopamine as L-3,4 dihydroxyphenylalanine, combine the catechol group of L-3,4 dihydroxyphenylalanine and the ammonia of lysine
Base functional group is considered simulating the component of sticking of Mfp-5 in marine organisms mussel well, realizes in wet environment to matrix
The attachment on surface.Dopamine can easily be dissolved oxygen in aqueous solution and be aoxidized, and then cause from poly- cross-linking reaction, almost
Any solid material surface forms the composite layer of close attachment.The characteristics of dopamine is from poly- duplex surface modification technology: 1)
Economical and efficient, environmentally protective, easy to operate, the surface for being suitable for almost any basis material is modified, and to the outer of material
There is no limit for shape and size.2) there are catechol active function groups by the coated material surface of dopamine, can carries out
Secondary response realizes the further functionalization of material surface.3) functional molecular synthesized according to bionic principle, can be by wherein
Dopamine biomimetic features unit by its secure anchorage on the surface of the material, assign material surface more preferably performance.Therefore, dopamine
Surface property can be optimized from the modified seperation film of poly- composite algorithm and assign film surface hydrophily, antifouling property, anti-microbial property,
Biocompatibility etc. has wide application space and development in separation membrane surface modification or even the modified direction of solid material surface
Prospect.
Summary of the invention
The purpose of the present invention is to provide a kind of PVDF/PDA composite membrane with super hydrophilicity.It is of the present invention multiple
Close that membrane structure refers to due to a large amount of PDA microballoons the in-situ preparation on film upper and lower surfaces and fenestra wall and modified obtained film is whole
Hydrophiling structure, wherein film section is the spongelike structure being interconnected between PDA microballoon tiling cover film hole wall but fenestra.Due to
The presence of film microreactor effect in the good hydrophily of dopamine itself and modifying process, so that modified obtained PVDF/PDA
Composite membrane has good hydrophily, antifouling property and biocompatibility, and maintains the backbone structure of Kynoar
It is not destroyed, that is, remains the good physical property of polyvinylidene fluoride film, have in the fields such as water filtration, purification and biomedicine
Wide application value.Preparation process of the present invention is simple, easily operated, and modified effect is significant, low for equipment requirements, is easy to industry
Change and implements.
To achieve the above object, the present invention adopts the following technical scheme:
Utilize the adhesion property of dopamine and its complicated physics between pvdf membrane, chemical bond and dopamine
The characteristics of polymerizeing balling-up in certain buffer solution pvdf membrane is added to the buffer solution and magnetic force of dopamine in different time points
After stirring certain number of days, the modified PVDF/PDA structure of composite membrane of PDA microballoon in-situ preparation is obtained.
Preparation method specifically:
Dopamine is added in buffer solution, after magnetic agitation 24-72h, addition pvdf membrane, magnetic agitation 3-5 days.
Wherein the buffer solution of the dopamine is first by deionized water and ethyl alcohol, isopropanol or ethylene glycol with certain
Ratio mixing, then it is configured to certain density Tris phosphate buffer.
Deionized water and the volume ratio of ethyl alcohol, isopropanol or ethylene glycol are 5:1-1 in the buffer solution of the dopamine:
1。
The concentration of dopamine is 1 ~ 10mg/mL in the dopamine buffer solution.
The partial size of PDA microballoon is 0.1-1 microns.
Remarkable advantage of the invention is:
(1) polyvinylidene fluoride material is modified using the dopamine with excellent hydrophily and biocompatibility, with
Pure pvdf membrane is compared, and obtained PVDF/PDA composite membrane is former on film upper and lower surfaces and fenestra wall due to a large amount of PDA microballoons
Position generates and modified obtained film entirety hydrophiling structure, and entire membrane structure is even up to super hydrophilic state, and because modified
The presence of film microreactor effect in the process, so that obtained PVDF/PDA composite membrane hydrophily when as water treatment applications film
It can be greatly improved with antifouling property, while the biocompatibility of film is also improved, and is remained and gathered inclined fluorine
The good physical property of vinyl film is with a wide range of applications in the fields such as water filtration, purification and biomedicine；
(2) in previous study on the modification, PDA always plays the effect of intermediate, modified often as simple surface
The method of additive in object or blending and modifying, surface coating PDA only gives only the preferable performance of film surface, but often film
Properties can not be improved, limit film filtering etc. in application；Using the blending and modifying of PDA nano particle,
PDA particle is easy to be embedded in film forming procedure is blended, and causes the performance of PDA that cannot embody completely；And in the present invention, directly
It connects and comes Modified Membrane, the performance of PDA microballoon in-situ preparation and PDA in entire membrane structure for PDA as main " construction material "
It is completely embodied, the overall performance for the PVDF/PDA composite membrane being prepared is preferable.In the present invention simultaneously, it will can control
The PDA microballoon of size and uniform particle sizes are applied in the modification of pvdf membrane, the PDA microballoon of uniform particle sizes can for secondary response and
Further functionalization provides a good platform；
(3) the PVDF/PDA structure of composite membrane of this method preparation has the advantage that 1. there is good hydrophily；2. having
There is good antifouling property；3. energy with good stability；4. having good biocompatibility；5. modified effect is aobvious
It writing, preparation process is simple, and it is easily operated, it is low for equipment requirements, it is easy to industrializing implementation.
Detailed description of the invention
Fig. 1 is the scanning electron microscope (SEM) photograph of the PVDF/PDA structure of composite membrane obtained with super hydrophilicity of embodiment 1；Wherein
A, B, C respectively represent the front of PVDF original film, reverse side and section；D, E, F respectively represent the front of PVDF/PDA composite membrane, reverse side
And section；
Fig. 2 is the contact angular data figure of the PVDF/PDA structure of composite membrane obtained with super hydrophilicity of embodiment 2；Its
Middle M0-A and M0-B respectively represents the obverse and reverse contact angle size of PVDF original film；M1-A and M1-B respectively represent PVDF/PDA
The obverse and reverse contact angle size of composite membrane；
Fig. 3 is the hemolysis rate figure of the PVDF/PDA structure of composite membrane obtained with super hydrophilicity of embodiment 1；Wherein M0
For PVDF original film；M1 is PVDF/PDA Composite Films Composite films.
Specific embodiment
In order to which the present invention is further explained, the present invention enumerates following embodiment, but the present invention is not limited to following embodiments.
Embodiment 1
First deionized water is mixed with dehydrated alcohol with the volume ratio of 5:1, then Tris phosphate buffer is dissolved in into ethyl alcohol
In the mixed liquor of water, it is made into the solution that Tris concentration is 10 mmol/L, finally dopamine powder is dissolved into solution, is made
Dopamine concentration is 1 mg/ml, and dopamine buffer solution first stirs for 24 hours after preparing, and continues stirring 3 after PVDF original film then is added
It, is cleaned after the completion of stirring with deionized water, naturally dry, obtains modified PVDF/PDA composite membrane.
Embodiment 2
First deionized water is mixed with dehydrated alcohol with the volume ratio of 4:1, then Tris phosphate buffer is dissolved in into ethyl alcohol
In the mixed liquor of water, it is made into the solution that Tris concentration is 10 mmol/L, finally dopamine powder is dissolved into solution, is made
Dopamine concentration is 2 mg/ml, and dopamine buffer solution first stirs 48h after preparing, and continues stirring 4 after PVDF original film then is added
It, is cleaned after the completion of stirring with deionized water, naturally dry, obtains modified PVDF/PDA composite membrane.
Embodiment 3
First deionized water is mixed with dehydrated alcohol with the volume ratio of 3:1, then Tris phosphate buffer is dissolved in into ethyl alcohol
In the mixed liquor of water, it is made into the solution that Tris concentration is 10 mmol/L, finally dopamine powder is dissolved into solution, is made
Dopamine concentration is 4 mg/ml, and dopamine buffer solution first stirs 72h after preparing, and continues stirring 3 after PVDF original film then is added
It, is cleaned after the completion of stirring with deionized water, naturally dry, obtains modified PVDF/PDA composite membrane.
Embodiment 4
First deionized water is mixed with dehydrated alcohol with the volume ratio of 2:1, then Tris phosphate buffer is dissolved in into ethyl alcohol
In the mixed liquor of water, it is made into the solution that Tris concentration is 10 mmol/L, finally dopamine powder is dissolved into solution, is made
Dopamine concentration is 5 mg/ml, and dopamine buffer solution first stirs for 24 hours after preparing, and continues stirring 3 after PVDF original film then is added
It, is cleaned after the completion of stirring with deionized water, naturally dry, obtains modified PVDF/PDA composite membrane.
Embodiment 5
First deionized water is mixed with dehydrated alcohol with the volume ratio of 5:4, then Tris phosphate buffer is dissolved in into ethyl alcohol
In the mixed liquor of water, it is made into the solution that Tris concentration is 10 mmol/L, finally dopamine powder is dissolved into solution, is made
Dopamine concentration is 6 mg/ml, and dopamine buffer solution first stirs 48h after preparing, and continues stirring 4 after PVDF original film then is added
It, is cleaned after the completion of stirring with deionized water, naturally dry, obtains modified PVDF/PDA composite membrane.
Embodiment 6
First deionized water is mixed with dehydrated alcohol with the volume ratio of 4:3, then Tris phosphate buffer is dissolved in into ethyl alcohol
In the mixed liquor of water, it is made into the solution that Tris concentration is 10 mmol/L, finally dopamine powder is dissolved into solution, is made
Dopamine concentration is 8 mg/ml, and dopamine buffer solution first stirs 72h after preparing, and continues stirring 5 after PVDF original film then is added
It, is cleaned after the completion of stirring with deionized water, naturally dry, obtains modified PVDF/PDA composite membrane.
Embodiment 7
First deionized water is mixed with dehydrated alcohol with the volume ratio of 3:2, then Tris phosphate buffer is dissolved in into ethyl alcohol
In the mixed liquor of water, it is made into the solution that Tris concentration is 10 mmol/L, finally dopamine powder is dissolved into solution, is made
Dopamine concentration is 10 mg/ml, and dopamine buffer solution first stirs for 24 hours after preparing, and continues to stir after PVDF original film then is added
It 3 days, is cleaned after the completion of stirring with deionized water, naturally dry, obtains modified PVDF/PDA composite membrane.
Embodiment 8
First deionized water is mixed with dehydrated alcohol with the volume ratio of 1:1, then Tris phosphate buffer is dissolved in into ethyl alcohol
In the mixed liquor of water, it is made into the solution that Tris concentration is 10 mmol/L, finally dopamine powder is dissolved into solution, is made
Dopamine concentration is 4 mg/ml, and dopamine buffer solution first stirs 48h after preparing, and continues stirring 4 after PVDF original film then is added
It, is cleaned after the completion of stirring with deionized water, naturally dry, obtains modified PVDF/PDA composite membrane.
Fig. 1 is the scanning electron microscope (SEM) photograph with the PVDF/PDA structure of composite membrane of super hydrophilicity；Wherein A, B, C are respectively represented
The front of PVDF original film, reverse side and section；D, E, F respectively represent the front of PVDF/PDA composite membrane, reverse side and section；It can by figure
Obtain, PDA microballoon is evenly distributed on the upper and lower surfaces and fenestra wall of pvdf membrane, but on fenestra wall PDA microballoon quantity it is remote
Much larger than the upper and lower surfaces of film, while a large amount of existing PDA microballoons are not also complete by the fenestra on film upper and lower surfaces and section
Full blocking；
Fig. 2 is the contact angular data figure with the PVDF/PDA structure of composite membrane of super hydrophilicity；It can be obtained from the figure that arriving, PVDF
The obverse and reverse contact angle of former film is respectively 103.1 ° and 105.3 °, and the obverse and reverse contact angle of PVDF/PDA composite membrane
Respectively 9.7 ° and 13.5 °, illustrates that the hydrophily of modified caudacoria has obtained significantly improving, reach super hydrophilic state；
Fig. 3 is the hemolysis rate figure with the PVDF/PDA structure of composite membrane of super hydrophilicity；Wherein M0:PVDF original film；M1:
PVDF/PDA composite membrane；Eg1: the leaching liquor of film is all added in experimental group；Eg2: physiological saline and film leaching liquor in experimental group
Volume ratio be 1:1；Eg3: the volume ratio of physiological saline and film leaching liquor is 4:1 in experimental group；It can be obtained from the figure that arriving, PVDF original film
Hemolysis rate be all larger than 5%, there is a degree of haemolysis, and the hemolysis rate of PVDF/PDA composite membrane is both less than 5%, it is believed that
There is no haemolysis, i.e., the biocompatibility of modified caudacoria is better than PVDF original film.
The foregoing is merely presently preferred embodiments of the present invention, all equivalent changes done according to scope of the present invention patent with
Modification, is all covered by the present invention.
Claims (6)
1. a kind of PVDF/PDA composite membrane with super hydrophilicity, it is characterised in that: the composite membrane is that PDA microballoon exists
In-situ preparation on pvdf membrane upper and lower surfaces and fenestra wall and modified obtained film entirety hydrophiling structure, wherein film section is PDA
The spongelike structure being interconnected between microballoon tiling cover film hole wall but fenestra；Preparation method are as follows: dopamine is added and is buffered
In solution, after magnetic agitation 24-72h, addition pvdf membrane, magnetic agitation 3-5 days.
2. the PVDF/PDA composite membrane according to claim 1 with super hydrophilicity, it is characterised in that: dopamine is slow
The concentration rushed in solution is 1 ~ 10mg/mL.
3. the PVDF/PDA composite membrane according to claim 1 with super hydrophilicity, it is characterised in that: the buffering
Solution is first to mix deionized water in certain proportion with ethyl alcohol, isopropanol or ethylene glycol, then be configured to certain density
Tris phosphate buffer.
4. the PVDF/PDA composite membrane according to claim 1 with super hydrophilicity, it is characterised in that: deionized water with
The volume ratio of ethyl alcohol, isopropanol or ethylene glycol is 5:1-1:1.
5. the PVDF/PDA composite membrane according to claim 1 with super hydrophilicity, it is characterised in that: PDA microballoon is equal
Be distributed on the upper and lower surfaces and fenestra wall of pvdf membrane evenly, but on fenestra wall the quantity of PDA microballoon be far longer than film it is upper,
Lower surface.
6. the PVDF/PDA composite membrane according to claim 1 with super hydrophilicity, it is characterised in that: PDA microballoon
Partial size is 0.1-1 microns.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710829883.0A CN107486037B (en) | 2017-09-15 | 2017-09-15 | A kind of PVDF/PDA composite membrane with super hydrophilicity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710829883.0A CN107486037B (en) | 2017-09-15 | 2017-09-15 | A kind of PVDF/PDA composite membrane with super hydrophilicity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107486037A CN107486037A (en) | 2017-12-19 |
| CN107486037B true CN107486037B (en) | 2019-11-12 |
Family
ID=60652356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710829883.0A Active CN107486037B (en) | 2017-09-15 | 2017-09-15 | A kind of PVDF/PDA composite membrane with super hydrophilicity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107486037B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108752813B (en) * | 2018-05-25 | 2020-08-07 | 福州大学 | Polydopamine/ionic liquid/plant fiber blend membrane and preparation method thereof |
| CN108905647B (en) * | 2018-06-19 | 2021-07-09 | 杭州安诺过滤器材有限公司 | Preparation method of hydrophilic polyvinylidene fluoride microfiltration membrane |
| CN108816057B (en) * | 2018-06-25 | 2021-04-27 | 福州大学 | Polydopamine-ionic liquid composite membrane and preparation method thereof |
| CN110026092B (en) * | 2019-04-17 | 2021-09-28 | 南京大学 | Nano composite membrane for heavy metal interception and preparation method thereof |
| CN111701465A (en) * | 2020-06-30 | 2020-09-25 | 福州大学 | Super hydrophilic SiO2Preparation of/PDAus/PVDF composite membrane |
| CN111701464A (en) * | 2020-06-30 | 2020-09-25 | 福州大学 | Super-hydrophilic beta-FeOOH/PDAus/PVDF composite membrane and preparation and application thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103041721B (en) * | 2012-12-27 | 2014-10-15 | 浙江大学 | Surface modification method for polymer separation membrane |
| KR102080283B1 (en) * | 2013-10-04 | 2020-02-21 | 주식회사 엘지화학 | Surface-modified membrane and method of modifyng the membrane surface |
| CN107149881B (en) * | 2016-03-02 | 2019-11-08 | 天津工业大学 | A kind of dopamine modifying polymer film and preparation method thereof |
| CN105582822A (en) * | 2016-03-10 | 2016-05-18 | 台州学院 | Preparation method of dopamine-modified polysulfone membrane |
| CN106757789B (en) * | 2017-01-11 | 2019-01-08 | 西南交通大学 | A kind of preparation method of super hydrophilic polyvinylidene fluoride/poly-dopamine laminated film |
-
2017
- 2017-09-15 CN CN201710829883.0A patent/CN107486037B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN107486037A (en) | 2017-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107486037B (en) | A kind of PVDF/PDA composite membrane with super hydrophilicity | |
| Yang et al. | Bioadhesion-inspired surface engineering constructing robust, hydrophilic membranes for highly-efficient wastewater remediation | |
| CN106731886B (en) | Preparation method of mesoporous composite membrane | |
| CN104971631B (en) | A kind of preparation method of high flux PVDF perforated membranes | |
| CN108905653B (en) | Preparation method and application of hyperbranched zwitterion modified polyvinylidene fluoride oil-water emulsion separation membrane | |
| CN103435829A (en) | Nanometer functionalization surface modification method based on o-dihydroxybenzene derivatives | |
| CN105056891B (en) | Biological carbon composite of graphene modified and its preparation method and application | |
| CN107753949A (en) | Black phosphorus nanometer sheet, composite aquogel and preparation method and application | |
| EP3471864B1 (en) | Periodic mesoporous organosilica-doped nanocomposite membranes and systems including same | |
| CN105749876B (en) | A kind of preparation method of chitosan-modified graphene oxide quantum dot sorbing material | |
| CN103480284A (en) | Pollution-resistant polyamide composite membrane and preparation method thereof | |
| CN109906248B (en) | Quinone curable compositions and adhesive compositions comprising the same | |
| CN103418255B (en) | A kind of thermo-sensitive type ultrafiltration membrane and preparation method thereof | |
| CN112175434A (en) | Anti-fouling gel particle containing rare earth/anti-fouling agent and preparation method thereof | |
| CN110404421A (en) | A kind of preparation method of Janus Kynoar (PVDF) seperation film | |
| CN108378025A (en) | A kind of farm chemical carrier and the preparation method and application thereof | |
| CN102702554B (en) | Preparation method of copolymer grafted carbon nano-tube super-hydrophobic material | |
| Nian et al. | High-performance Co-based ZIF-67 tubular membrane achieved by ZnO-induced synthesis for highly efficient Pervaporation separation of methanol/methyl tert-butyl ether mixture | |
| Li et al. | Water-and acid-sensitive Cu2O@ Cu-MOF nano sustained-release capsules with superior antifouling behaviors | |
| Li et al. | “Button and buttonhole” supramolecular structure enables the self-healing behaviors of functionalized poly (ether sulfone) membranes for osmotic power generation | |
| CN111187531B (en) | Bionic antifouling paint and preparation method and application thereof | |
| CN103406034B (en) | A kind of preparation method of the polyether block amide microporous barrier for Membrane Materials process | |
| CN209317459U (en) | A kind of novel organic ultrafiltration membrane | |
| CN110548410A (en) | Polypeptide modified graphene oxide modified composite antibacterial forward osmosis membrane and preparation method thereof | |
| Samnani et al. | A novel reverse osmosis membrane modified by polyvinyl alcohol with maleic anhydride crosslinking |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |